Bristol-Myers Squibb Co. (NYSE:BMY) has a beta value of 0.37 and has seen 19.73 million shares traded in the last trading session. The company, currently valued at $104.32B, closed the last trade at $51.59 per share which meant it lost -$0.75 on the day or -1.43% during that session. The BMY stock price is -37.76% off its 52-week high price of $71.07 and 7.77% above the 52-week low of $47.58. If we look at the company’s 10-day average daily trading volume, we find that it stood at 28.6 million shares traded. The 3-month trading volume is 16.97 million shares.
Bristol-Myers Squibb Co. (NYSE:BMY) trade information
Sporting -1.43% in the red in last session, the stock has traded in the red over the last five days, when the BMY stock price touched $51.59 or saw a rise of 6.25%. Year-to-date, Bristol-Myers Squibb Co. shares have moved 0.55%, while the 5-day performance has seen it change -5.10%. Over the past 30 days, the shares of Bristol-Myers Squibb Co. (NYSE:BMY) have changed 4.35%. Short interest in the company has seen 32.65 million shares shorted with days to cover at 2.24.
Bristol-Myers Squibb Co. (BMY) estimates and forecasts
Figures show that Bristol-Myers Squibb Co. shares have underperformed across the wider relevant industry. The company’s shares have lost -12.60% over the past 6 months, with this year growth rate of -11.98%, compared to 13.60% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -29.30% and -6.90% for the next quarter. Revenue growth from the last financial year stood is estimated to be 2.10%.
13 analysts offering their estimates for the company have set an average revenue estimate of $10.49 billion for the current quarter. 13 have an estimated revenue figure of $10.58 billion for the next quarter concluding in Jun 2024.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 5.14% over the past 5 years. Earnings growth for 2024 is a modest -9.19% while over the next 5 years, the company’s earnings are expected to decrease by -2.80%.
BMY Dividends
Bristol-Myers Squibb Co. is expected to release its next earnings report on April 25 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 2.31 at a share yield of 4.48%. The company’s dividend yield has gone up over the past 12 months.
Bristol-Myers Squibb Co. (NYSE:BMY)’s Major holders
Insiders own 0.10% of the company shares, while shares held by institutions stand at 79.17% with a share float percentage of 79.25%. Investors are also buoyed by the number of investors in a company, with Bristol-Myers Squibb Co. having a total of 3,042 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc with over 203.74 million shares worth more than $13.03 billion. As of Jun 29, 2023, Vanguard Group Inc held 9.75% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 172.67 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $11.04 billion and represent 8.27% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. As of Jun 29, 2023, the former fund manager holds about 3.14% shares in the company for having 65.55 million shares of worth $4.19 billion while later fund manager owns 50.02 million shares of worth $3.2 billion as of Jun 29, 2023, which makes it owner of about 2.39% of company’s outstanding stock.
